Importing Pharmaceuticals into Singapore: A Practical Guide
Singapore is the regional hub for pharmaceutical distribution and clinical trials across Asia Pacific, with a concentration of manufacturing, regional distribution centres and CROs. It runs a tightly controlled but efficient import regime: therapeutic products are regulated by the Health Sciences Authority, and every consignment clears through Singapore Customs on an electronic permit. This guide covers the licences the importer needs, how clinical research material moves, and the points where shipments are most often delayed.
Who regulates pharmaceutical imports into Singapore
Therapeutic products in Singapore are regulated by the Health Sciences Authority (HSA) under the Health Products Act. HSA registers products, licenses importers and wholesalers, and enforces good distribution practice based on the PIC/S GDP standard. Customs clearance is handled by Singapore Customs through the TradeNet system, where a permit is required for each import even though Singapore is otherwise a free port.
What the importer needs
To import therapeutic products commercially, the Singapore importer generally needs:
- An HSA Importer's Licence for therapeutic products, and a Wholesaler's Licence if the products will be distributed onward.
- GDP certification to the Singapore standard, with a documented quality system and temperature control.
- Product registration. The product is registered with HSA, or covered by a specific import approval or exemption.
- A Customs import permit obtained through TradeNet for each consignment, declaring the goods and the controlling agency approval.
| Document | Purpose |
|---|---|
| Customs import permit (TradeNet) | Authorises the specific consignment to enter. |
| HSA importer's or wholesaler's licence | Evidence the importer is authorised for therapeutic products. |
| Product registration or import approval | Shows the product may be imported. |
| Commercial or proforma invoice and packing list | Customs valuation and description. |
| GDP and temperature records | Proof the distribution chain and cold chain were maintained. |
| Dangerous-goods declaration | For dry ice, certain biologicals and other regulated goods. |
Clinical research material
Import of clinical research material for a trial in Singapore is tied to the trial approval. A clinical trial of a therapeutic product needs a Clinical Trial Certificate or Clinical Trial Authorisation from HSA, along with ethics committee approval, before material moves. HSA issues import approvals for clinical research material, and the importing party must handle it under GDP with full accountability from receipt through dispensing and return.
Cold chain and special categories
- Cold chain. Singapore's climate makes temperature control unforgiving. Continuous data and a documented excursion response are expected.
- Narcotics and psychotropics. These need additional HSA approval on top of the standard import licence.
- Dangerous goods. Dry ice and certain biologicals require the correct transport declaration and packaging.
Where shipments get held up
- 1No valid Customs import permit is in place before the goods arrive.
- 2The importer's HSA licence does not cover the product, or the product is not registered or approved for import.
- 3Temperature data shows a gap, forcing a quality decision.
- 4Controlled-substance or dangerous-goods documentation is incomplete.
- 5Invoice or permit details do not match the physical consignment.
Frequently asked questions
Yes. The Singapore importer needs an HSA Importer's Licence for therapeutic products, and a Wholesaler's Licence to distribute onward, both under GDP. The product must be registered with HSA or covered by a specific import approval, and each consignment needs a Customs import permit.